{"Symbol": "ARWR", "AssetType": "Common Stock", "Name": "Arrowhead Pharmaceuticals Inc", "Description": "Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.", "CIK": "879407", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "177 EAST COLORADO BOULEVARD, PASADENA, CA, UNITED STATES, 91105", "OfficialSite": "https://arrowheadpharma.com", "FiscalYearEnd": "September", "LatestQuarter": "2025-12-31", "MarketCapitalization": "8936855000", "EBITDA": "325650000", "PERatio": "39.89", "PEGRatio": "-1.32", "BookValue": "4.137", "DividendPerShare": "None", "DividendYield": "None", "EPS": "1.6", "RevenuePerShareTTM": "7.97", "ProfitMargin": "0.185", "OperatingMarginTTM": "0.155", "ReturnOnAssetsTTM": "0.143", "ReturnOnEquityTTM": "0.755", "RevenueTTM": "1090981000", "GrossProfitTTM": "1090981000", "DilutedEPSTTM": "1.6", "QuarterlyEarningsGrowthYOY": "0.098", "QuarterlyRevenueGrowthYOY": "104.61", "AnalystTargetPrice": "81.36", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "7", "AnalystRatingHold": "4", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "39.89", "ForwardPE": "111.11", "PriceToSalesRatioTTM": "8.19", "PriceToBookRatio": "15.73", "EVToRevenue": "7.64", "EVToEBITDA": "22.52", "Beta": "1.222", "52WeekHigh": "76.76", "52WeekLow": "9.57", "50DayMovingAverage": "66.83", "200DayMovingAverage": "35.9", "SharesOutstanding": "140032000", "SharesFloat": "121755000", "PercentInsiders": "3.804", "PercentInstitutions": "82.470", "DividendDate": "None", "ExDividendDate": "None"}